The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
High-throughput screening assays for the identification of chemical probes
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of Fluorescence Spectroscopy
Lakowicz, J. R. (1999) · Springer eBooks · doi:10.1007/978-1-4757-3061-6 · Cited by 26,947
Principles of Fluorescence Spectroscopy
(2006) · Springer eBooks · doi:10.1007/978-0-387-46312-4 · Cited by 19,339
Quantum dot bioconjugates for imaging, labelling and sensing
Medintz, I. L., Uyeda, H. T., Goldman, E. R., & Mattoussi, H. (2005) · Nature Materials · doi:10.1038/nmat1390 · Cited by 6,229
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
The Fluorescent Toolbox for Assessing Protein Location and Function
Giepmans, B. N. G., Adams, S. R., Ellisman, M. H., & Tsien, R. Y. (2006) · Science · doi:10.1126/science.1124618 · Cited by 2,770
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B. L., Cooper, T. K., Myers, L., Klein, E. C., Liu, G., Calvi, C., et al. (2006) · Science · doi:10.1126/science.1124287 · Cited by 1,794
Application of a Microtechnique to Viral Serological Investigations
Sever, J. L. (1962) · The Journal of Immunology · doi:10.4049/jimmunol.88.3.320 · Cited by 1,614
PTC124 targets genetic disorders caused by nonsense mutations
Welch, E. M., Barton, E. R., Zhuo, J., Tomizawa, Y., Friesen, W. J., Trifillis, P., Paushkin, S., Patel, M., Trotta, C. R., Hwang, S., et al. (2007) · Nature · doi:10.1038/nature05756 · Cited by 1,137
Targeting the Hedgehog pathway in cancer
Rubin, L. L., & de Sauvage, F. J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2086 · Cited by 949
High-Density Miniaturized Thermal Shift Assays as a General Strategy for Drug Discovery
Pantoliano, M. W., Petrella, E. C., Kwasnoski, J. D., Lobanov, V. S., Myslik, J., Graf, E., Carver, T., Asel, E., Springer, B. A., Lane, P., et al. (2001) · SLAS Discovery · doi:10.1177/108705710100600609 · Cited by 893
Protease Inhibitors: Current Status and Future Prospects
Leung, D., Abbenante, G., & Fairlie, D. P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990412m · Cited by 883
Online Mendelian Inheritance in Man 'OMIM'.
Amladi, S. (2003) · PubMed · Cited by 875
Inglese, J., Auld, D. S., Jadhav, A., Johnson, R. L., Simeonov, A., Yasgar, A., Zheng, W., & Austin, C. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604348103 · Cited by 792
Self-citationThe Handbook: A Guide to Fluorescent Probes and Labeling Technologies
Haugland, R. P. (2005) · Cited by 755
Imaging protein molecules using FRET and FLIM microscopy
Wallrabe, H., & Periasamy, A. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.12.002 · Cited by 724
Fluorescence Correlation Spectroscopy
(2011) · SpringerReference · doi:10.1007/springerreference_33960 · Cited by 714
Protein phosphorylation in signaling – 50 years and counting
Pawson, T., & Scott, J. D. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.04.013 · Cited by 694
Zlokarnik, G., Negulescu, P. A., Knapp, T. E., Mere, L., Burres, N., Feng, L., Whitney, M., Roemer, K., & Tsien, R. Y. (1998) · Science · doi:10.1126/science.279.5347.84 · Cited by 690
Chemical and physiological characterization of fluo-4 Ca2+-indicator dyes
Gee, K. R., Brown, K. A., Chen, W.-N. U., Bishop-Stewart, J., Gray, D., & Johnson, I. (2000) · Cell Calcium · doi:10.1054/ceca.1999.0095 · Cited by 643
Pfleger, K. D. G., & Eidne, K. A. (2006) · Nature Methods · doi:10.1038/nmeth841 · Cited by 569
Structural basis for the spectral difference in luciferase bioluminescence
Nakatsu, T., Ichiyama, S., Hiratake, J., Saldanha, A., Kobashi, N., Sakata, K., & Kato, H. (2006) · Nature · doi:10.1038/nature04542 · Cited by 517
Progress in Lanthanides as Luminescent Probes
Hemmilä, I., & Laitala, V. (2005) · Journal of Fluorescence · doi:10.1007/s10895-005-2826-6 · Cited by 458
Bioluminescent Assays for High-Throughput Screening
Fan, F., & Wood, K. V. (2007) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2006.053 · Cited by 449
Discovery and Cocrystal Structure of Benzodiazepinedione HDM2 Antagonists That Activate p53 in Cells
Grasberger, B. L., Lu, T., Schubert, C., Parks, D. J., Carver, T. E., Koblish, H. K., Cummings, M. D., LaFrance, L. V., Milkiewicz, K. L., Calvo, R. R., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049137g · Cited by 432
Origin of nanomechanical cantilever motion generated from biomolecular interactions
Wu, G., Ji, H., Hansen, K., Thundat, T., Datar, R., Cote, R., Hagan, M. F., Chakraborty, A. K., & Majumdar, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1560 · Cited by 415
Inverse, protean, and ligand‐selective agonism: matters of receptor conformation
KENAKIN, T. (2001) · The FASEB Journal · doi:10.1096/fj.00-0438rev · Cited by 408
BARNETT, S. F., DEFEO-JONES, D., FU, S., HANCOCK, P. J., HASKELL, K. M., JONES, R. E., KAHANA, J. A., KRAL, A. M., LEANDER, K., LEE, L. L., et al. (2005) · Biochemical Journal · doi:10.1042/bj20041140 · Cited by 396
Nonleadlikeness and leadlikeness in biochemical screening
Rishton, G. M. (2003) · Drug Discovery Today · doi:10.1016/s1359644602025722 · Cited by 381
The 7 TM G‐Protein‐Coupled Receptor Target Family
Jacoby, E., Bouhelal, R., Gerspacher, M., & Seuwen, K. (2006) · ChemMedChem · doi:10.1002/cmdc.200600134 · Cited by 359
A High-Throughput Screen for Aggregation-Based Inhibition in a Large Compound Library
Feng, B. Y., Simeonov, A., Jadhav, A., Babaoglu, K., Inglese, J., Shoichet, B. K., & Austin, C. P. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061317y · Cited by 358
Self-citationVisualization of nitric oxide in living cells by a copper-based fluorescent probe
Lim, M. H., Xu, D., & Lippard, S. J. (2006) · Nature Chemical Biology · doi:10.1038/nchembio794 · Cited by 353
Ullman, E. F., Kirakossian, H., Singh, S., Wu, Z. P., Irvin, B. R., Pease, J. S., Switchenko, A. C., Irvine, J. D., Dafforn, A., & Skold, C. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5426 · Cited by 335
Nuclear Receptor Minireview Series
Olefsky, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100047200 · Cited by 308
Fluorescence Polarization and Anisotropy in High Throughput Screening: Perspectives and Primer
Owicki, J. C. (2000) · SLAS Discovery · doi:10.1177/108705710000500501 · Cited by 303
Identifying off-target effects and hidden phenotypes of drugs in human cells
MacDonald, M. L., Lamerdin, J., Owens, S., Keon, B. H., Bilter, G. K., Shang, Z., Huang, Z., Yu, H., Dias, J., Minami, T., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio790 · Cited by 293
Pharmacological chaperones: potential treatment for conformational diseases
Bernier, V., Lagacé, M., Bichet, D. G., & Bouvier, M. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.05.003 · Cited by 283
Higher-throughput, label-free, real-time molecular interaction analysis
Rich, R. L., & Myszka, D. G. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2006.10.040 · Cited by 264
An Intuitive Look at the Relationship of Ki and IC50: A More General Use for the Dixon Plot
Burlingham, B. T., & Widlanski, T. S. (2003) · Journal of Chemical Education · doi:10.1021/ed080p214 · Cited by 263
Label-Free Assays on the BIND System
Cunningham, B. T., Li, P., Schulz, S., Lin, B., Baird, C. L., Gerstenmaier, J., Genick, C. C., Wang, F., Fine, E., & Laing, L. G. (2004) · SLAS DISCOVERY · doi:10.1177/1087057104267604 · Cited by 257
Zhang, X., Smith, D. L., Meriin, A. B., Engemann, S., Russel, D. E., Roark, M., Washington, S. L., Maxwell, M. M., Marsh, J. L., Thompson, L. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408936102 · Cited by 246
Yu, N., Atienza, J. M., Bernard, J., Blanc, S., Zhu, J., Wang, X., Xu, X., & Abassi, Y. A. (2006) · Analytical Chemistry · doi:10.1021/ac051695v · Cited by 237
Iversen, P. W., Eastwood, B. J., Sittampalam, G. S., & Cox, K. L. (2006) · SLAS Discovery · doi:10.1177/1087057105285610 · Cited by 237
NMR screening techniques in drug discovery and drug design
Stockman, B. J., & Dalvit, C. (2002) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/s0079-6565(02)00049-3 · Cited by 227
High-Throughput Screening: Update on Practices and Success
Fox, S., Farr-Jones, S., Sopchak, L., Boggs, A., Nicely, H. W., Khoury, R., & Biros, M. (2006) · SLAS Discovery · doi:10.1177/1087057106292473 · Cited by 217
Fluorescent-conjugated polymer superquenching facilitates highly sensitive detection of proteases
Kumaraswamy, S., Bergstedt, T., Shi, X., Rininsland, F., Kushon, S., Xia, W., Ley, K., Achyuthan, K., McBranch, D., & Whitten, D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402367101 · Cited by 216
Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs
Sazani, P., Kang, S.-H., Maier, M. A., Wei, C., Dillman, J., Summerton, J., Manoharan, M., & Kole, R. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.19.3965 · Cited by 212
Parker, G. J., Law, T. L., Lenoch, F. J., & Bolger, R. E. (2000) · SLAS Discovery · doi:10.1177/108705710000500204 · Cited by 208
Flow cytometry for high-throughput, high-content screening
Edwards, B. S., Oprea, T., Prossnitz, E. R., & Sklar, L. A. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.06.007 · Cited by 206
Ubistatins Inhibit Proteasome-Dependent Degradation by Binding the Ubiquitin Chain
Verma, R., Peters, N. R., D'Onofrio, M., Tochtrop, G. P., Sakamoto, K. M., Varadan, R., Zhang, M., Coffino, P., Fushman, D., Deshaies, R. J., et al. (2004) · Science · doi:10.1126/science.1100946 · Cited by 193
Branchini, B. R., Ablamsky, D. M., Murtiashaw, M. H., Uzasci, L., Fraga, H., & Southworth, T. L. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2006.10.043 · Cited by 188
Further concerns over Cheng-Prusoff analysis
Leff, P., & Dougall, I. G. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90080-4 · Cited by 185
Therapeutic Targets: Progress of Their Exploration and Investigation of Their Characteristics
Zheng, C. J., Han, L. Y., Yap, C. W., Ji, Z. L., Cao, Z. W., & Chen, Y. Z. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.2.4 · Cited by 185
Hamdan, F. F., Audet, M., Garneau, P., Pelletier, J., & Bouvier, M. (2005) · SLAS Discovery · doi:10.1177/1087057105275344 · Cited by 183
Dynamic and Label-Free Cell-Based Assays Using the Real-Time Cell Electronic Sensing System
Atienza, J. M., Yu, N., Kirstein, S. L., Xi, B., Wang, X., Xu, X., & Abassi, Y. A. (2006) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2006.4.597 · Cited by 178
Is Gα16 the optimal tool for fishing ligands of orphan G-protein-coupled receptors?
Kostenis, E. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01810-1 · Cited by 176
Charest, P. G., Terrillon, S., & Bouvier, M. (2005) · EMBO reports · doi:10.1038/sj.embor.7400373 · Cited by 172
High-Throughput Plasmodium falciparum Growth Assay for Malaria Drug Discovery
Baniecki, M. L., Wirth, D. F., & Clardy, J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01144-06 · Cited by 172
cAMP detection methods in HTS: selecting the best from the rest
Williams, C. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1306 · Cited by 170
Parks, D. J., LaFrance, L. V., Calvo, R. R., Milkiewicz, K. L., Gupta, V., Lattanze, J., Ramachandren, K., Carver, T. E., Petrella, E. C., Cummings, M. D., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.11.009 · Cited by 167
Rodems, S. M., Hamman, B. D., Lin, C., Zhao, J., Shah, S., Heidary, D., Makings, L., Stack, J. H., & Pollok, B. A. (2002) · ASSAY and Drug Development Technologies · doi:10.1089/154065802761001266 · Cited by 160
Jarecki, J., Chen, X., Bernardino, A., Coovert, D. D., Whitney, M., Burghes, A. H. M., Stack, J. H., & Pollok, B. A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi205 · Cited by 158
Mechanistic considerations in high-throughput screening
Copeland, R. A. (2003) · Analytical Biochemistry · doi:10.1016/s0003-2697(03)00346-4 · Cited by 157
Koltermann, A., Kettling, U., Bieschke, J., Winkler, T., & Eigen, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1421 · Cited by 155
Jones, L. R., Goun, E. A., Shinde, R., Rothbard, J. B., Contag, C. H., & Wender, P. A. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0586283 · Cited by 155
HERG-Lite®: A novel comprehensive high-throughput screen for drug-induced hERG risk
Wible, B. A., Hawryluk, P., Ficker, E. K., et al. (2005) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2005.03.008 · Cited by 150
Measurement of [Ca2+] Using the Fluorometric Imaging Plate Reader (FLIPR)
Sullivan, E., Tucker, E. M., & Dale, I. L. (2003) · Humana Press eBooks · doi:10.1385/1-59259-250-3:125 · Cited by 149
A Novel Membrane Potential-Sensitive Fluorescent Dye Improves Cell-Based Assays for Ion Channels
Baxter, D. F., Kirk, M., Garcia, A. F., Raimondi, A., Holmqvist, M., Flint, K., Bojanic, D., DiStefano, P. S., Curtis, R., & Xie, Y. (2002) · SLAS DISCOVERY · doi:10.1177/108705710200700110 · Cited by 147
Miniaturized HTS technologies – uHTS
Woelcke, J., & Ullmann, D. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01807-4 · Cited by 146
A High-Throughput Cell-Based Assay for Inhibitors of ABCG2 Activity
Henrich, C. J., Bokesch, H. R., Dean, M. C., Bates, S. E., Robey, R. W., Goncharova, E. I., Wilson, J. A., & McMahon, J. B. (2006) · SLAS DISCOVERY · doi:10.1177/1087057105284576 · Cited by 142
High Throughput Screening Technologies for Direct Cyclic AMP Measurement
Gabriel, D., Vernier, M., Pfeifer, M., Dasen, B., Tenaillon, L., & Bouhelal, R. (2003) · Assay and Drug Development Technologies · doi:10.1089/15406580360545107 · Cited by 136
Trinquet, E., Fink, M., Bazin, H., Grillet, F., Maurin, F., Bourrier, E., Ansanay, H., Leroy, C., Michaud, A., Durroux, T., et al. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.08.002 · Cited by 135
High Throughput Ion-Channel Pharmacology: Planar-Array-Based Voltage Clamp
Kiss, L., Bennett, P. B., Uebele, V. N., Koblan, K. S., Kane, S. A., Neagle, B., & Schroeder, K. S. (2003) · Assay and Drug Development Technologies · doi:10.1089/154065803321537845 · Cited by 134
A Comparison of ALPHAScreen, TR-FRET, and TRF as Assay Methods for FXR Nuclear Receptors
Glickman, J. F., Wu, X. Y., Mercuri, R., Illy, C., Bowen, B. R., He, Y., & Sills, M. A. (2002) · SLAS DISCOVERY · doi:10.1177/108705710200700102 · Cited by 133
Prendergast, G. C. (2004) · Wiley eBooks · doi:10.1002/047165616x · Cited by 129
Fluorescence readouts in HTS: no gain without pain?
Gribbon, P. M., & Sewing, A. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02895-2 · Cited by 128
Verkman, A. S. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00397.2003 · Cited by 126
High Throughput Assay Technologies for Ion Channel Drug Discovery
Zheng, W., Spencer, R. H., & Kiss, L. (2004) · Assay and Drug Development Technologies · doi:10.1089/1540658042584143 · Cited by 125
Self-citationEastwood, B. J., Farmen, M. W., Iversen, P. W., Craft, T. J., Smallwood, J. K., Garbison, K. E., DeLapp, N. W., & Smith, G. F. (2006) · SLAS DISCOVERY · doi:10.1177/1087057105285611 · Cited by 125
Wolff, C., Fuks, B., & Chatelain, P. (2003) · SLAS DISCOVERY · doi:10.1177/1087057103257806 · Cited by 117
Fluorescence Polarization: Past, Present and Future
Jameson, D., & Croney, J. C. (2003) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620703106298347 · Cited by 114
Oakley, R. H., Hudson, C. C., Cruickshank, R. D., Meyers, D. M., Payne, R. E., Rhem, S. M., & Loomis, C. R. (2002) · Assay and Drug Development Technologies · doi:10.1089/154065802761001275 · Cited by 112
High-content screening moves to the front of the line
Haney, S. A., LaPan, P., Pan, J., & Zhang, J. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.08.015 · Cited by 106
Predicting therapeutic value in the lead optimization phase of drug discovery
Kenakin, T. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1110 · Cited by 106
Turek-Etienne, T. C., Small, E. C., Soh, S. C., Xin, T. A., Gaitonde, P. V., Barrabee, E. B., Hart, R. F., & Bryant, R. W. (2003) · SLAS DISCOVERY · doi:10.1177/1087057103252304 · Cited by 102
Differential Inhibition of Inducible T Cell Cytokine Secretion by Potent Iron Chelators
Leung, S., Holbrook, A., King, B., Lu, H., Evans, V., Miyamoto, N. G., Mallari, C. R., Harvey, S., Davey, D., Ho, E., et al. (2005) · SLAS DISCOVERY · doi:10.1177/1087057104272295 · Cited by 96
A Continuous Spectrophotometric Assay for the Hepatitis C Virus Serine Protease
Zhang, R., Beyer, B. M., Durkin, J., Ingram, R. N., Njoroge, F. G., Windsor, W. T., & Malcolm, B. A. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4109 · Cited by 95
Eglen, R. M., Bossé, R., & Reisine, T. (2007) · Assay and Drug Development Technologies · doi:10.1089/adt.2007.062 · Cited by 90
G protein-coupled receptor microarrays for drug discovery
Ye, F., Lahiri, J., & Picard, L. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02779-x · Cited by 89
Kunapuli, P., Ransom, R. W., Murphy, K. L., Pettibone, D. J., Kerby, J., Grimwood, S., Zuck, P. D., Hodder, P., Lacson, R., Hoffman, I., et al. (2003) · Analytical Biochemistry · doi:10.1016/s0003-2697(02)00587-0 · Cited by 85
Self-citationDevelopment and Application of a GFP-FRET Intracellular Caspase Assay for Drug Screening*
Jones, J. M., Heim, R., Hare, E., Stack, J. H., & Pollok, B. A. (2000) · SLAS DISCOVERY · doi:10.1177/108705710000500502 · Cited by 84
Characterisation of Mammalian GLUT Glucose Transporters in a Heterologous Yeast Expression System
Wieczorke, R., Dlugai, S., Krampe, S., & Boles, E. (2003) · Cellular Physiology and Biochemistry · doi:10.1159/000071863 · Cited by 83
Determining Appropriate Substrate Conversion for Enzymatic Assays in High-Throughput Screening
Wu, G., Yuan, Y., & Hodge, C. N. (2003) · SLAS DISCOVERY · doi:10.1177/1087057103260050 · Cited by 81
Iyer, R., Barrese, A. A., Parakh, S., Parker, C. N., & Tripp, B. C. (2006) · SLAS DISCOVERY · doi:10.1177/1087057106289403 · Cited by 80
Reporter gene imaging of protein–protein interactions in living subjects
Massoud, T. F., Paulmurugan, R., De, A., Ray, P., & Gambhir, S. S. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.01.007 · Cited by 79
Tao, H., Ana, D. S., Guia, A., Huang, M., Ligutti, J., Walker, G., Sithiphong, K., Chan, F., Guoliang, T., Zozulya, Z., et al. (2004) · Assay and Drug Development Technologies · doi:10.1089/1540658042584251 · Cited by 79
González, J. E., & Maher, M. P. (2002) · Receptors and Channels · doi:10.3109/10606820214644 · Cited by 78
NMR-based techniques in the hit identification and optimisation processes
Pellecchia, M., Becattini, B., Crowell, K. J., Fattorusso, R., Forino, M., Fragai, M., Jung, D., Mustelin, T., & Tautz, L. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.6.597 · Cited by 77
Fluorescence polarization assay and inhibitor design for MDM2/p53 interaction
Zhang, R., Mayhood, T., Lipari, P., Wang, Y., Durkin, J., Syto, R., Gesell, J. J., McNemar, C., & Windsor, W. T. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.03.009 · Cited by 75
Charter, N. W., Kauffman, L., Singh, R., & Eglen, R. M. (2006) · SLAS DISCOVERY · doi:10.1177/1087057106286829 · Cited by 75
Resveratrol inhibits firefly luciferase
Bakhtiarova, A., Taslimi, P. M., Elliman, S. J., Kosinski, P. A., Hubbard, B. K., Kavana, M., & Kemp, D. M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.057 · Cited by 73
Yen, L., Magnier, M., Weissleder, R., Stockwell, B. R., & Mulligan, R. C. (2006) · RNA · doi:10.1261/rna.2300406 · Cited by 73
Correlation of High-Throughput Pregnane X Receptor (PXR) Transactivation and Binding Assays
Zhu, Z., Kim, S. T., Chen, T., Lin, J.-H., Bell, A., Bryson, J., Dubaquié, Y., Yan, N., Yanchunas, J., Xie, D., et al. (2004) · SLAS DISCOVERY · doi:10.1177/1087057104264902 · Cited by 70
GPCR Screening via ERK 1/2: A Novel Platform for Screening G Protein–Coupled Receptors
Osmond, R. I. W., Sheehan, A., Borowicz, R. A., Barnett, E., Harvey, G., Turner, C., Brown, A., Crouch, M. F., & Dyer, A. R. (2005) · SLAS DISCOVERY · doi:10.1177/1087057105277968 · Cited by 70
McDonald, O. B., Chen, W. J., Ellis, B., Hoffman, C. R., Overton, L. K., Rink, M., Smith, A., Marshalland, C. J., & Wood, E. R. (1999) · Analytical Biochemistry · doi:10.1006/abio.1998.3030 · Cited by 68
O’Boyle, D. R., Nower, P. T., Lemm, J. A., Valera, L., Sun, J.-H., Rigat, K. L., Colonno, R. J., & Gao, M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1346-1353.2005 · Cited by 68
Live Cell Quality Control and Utility of Real-Time Cell Electronic Sensing for Assay Development
Kirstein, S. L., Atienza, J. M., Xi, B., Zhu, J., Yu, N., Wang, X., Xu, X. Y., & Abassi, Y. A. (2006) · Assay and Drug Development Technologies · doi:10.1089/adt.2006.4.545 · Cited by 67
Miraglia, S. J., Swartzman, E. E., Mellentin, J. D., Evangelista, L., Smith, C. J. S., Gunawan, I., Lohman, K. L., Goldberg, E. M., Manian, B. S., & Yuan, P.-M. (1999) · SLAS DISCOVERY · doi:10.1177/108705719900400407 · Cited by 66
Development of Novel Assays for Proteolytic Enzymes Using Rhodamine-Based Fluorogenic Substrates
Grant, S. K., Sklar, J. G., & Cummings, R. T. (2002) · SLAS DISCOVERY · doi:10.1177/1087057102238627 · Cited by 63
Dupriez, V. J., Maes, K., Poul, E. L., Burgeon, E., & Detheux, M. (2002) · Receptors and Channels · doi:10.3109/10606820214646 · Cited by 63
Fluorescence polarization assay and inhibitor design for MDM2/p53 interaction
ZHANG, R., Mayhood, T., LIPARI, P., Wang, Y., Durkin, J., Syto, R., GESELL, J., McNemar, C., & Windsor, W. T. (2004) · Analytical Biochemistry · doi:10.1016/s0003-2697(04)00223-4 · Cited by 62
SpeedScreen: The “Missing Link” between Genomics and Lead Discovery
Zehender, H., Goff, F. L., Lehmann, N., Filipuzzi, I., & Mayr, L. M. (2004) · SLAS DISCOVERY · doi:10.1177/1087057104267605 · Cited by 60
Hodder, P., Mull, R., Cassaday, J., Berry, K., & Strulovici, B. (2004) · SLAS DISCOVERY · doi:10.1177/1087057104264038 · Cited by 60
Rüdiger, M., Haupts, U. M., Moore, K. J. M., & Pope, A. J. (2001) · SLAS DISCOVERY · doi:10.1177/108705710100600105 · Cited by 59
Wunder, F., Stasch, J., Hütter, J. F., Alonso‐Alija, C., Hüser, J., & Lohrmann, E. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2004.12.025 · Cited by 59
Zuck, P. D., Murray, E. M., Stec, E. M., Grobler, J. A., Simon, A. J., Strulovici, B., Inglese, J., Flores, O. A., & Ferrer, M. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.07.031 · Cited by 59
Self-citationA Homogeneous Enzyme Fragment Complementation Cyclic AMP Screen for GPCR Agonists
Golla, R., & Seethala, R. (2002) · SLAS DISCOVERY · doi:10.1177/1087057102238625 · Cited by 56
Application of NMR Screening in Drug Discovery
Fejzo, J., Lepre, C. A., & Xie, X. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033392796 · Cited by 56
Measuring human β-secretase (BACE1) activity using homogeneous time-resolved fluorescence
Kennedy, M. E., Wang, W., Song, L., Lee, J., Zhang, L., Wong, G., Wang, L., & Parker, E. M. (2003) · Analytical Biochemistry · doi:10.1016/s0003-2697(03)00253-7 · Cited by 55
Direct Quantification of Analyte Concentration by Resonant Acoustic Profiling
Godber, B., Thompson, K. S. J., Rehak, M., Uludağ, Y., Kelling, S., Sleptsov, A., Frogley, M. D., Wiehler, K., Whalen, C., & Cooper, M. A. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.053249 · Cited by 55
Application of Scintillation Proximity Assay in Drug Discovery
Wu, S., & Liu, B. (2005) · BioDrugs · doi:10.2165/00063030-200519060-00005 · Cited by 54
Mapping Biochemical Networks with Protein Fragment Complementation Assays
Remy, I., & Michnick, S. W. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2425-7_31 · Cited by 53
Peppard, J., Glickman, J. F., He, Y., Hu, S., Doughty, J., & GOLDBERG, R. L. (2003) · SLAS DISCOVERY · doi:10.1177/1087057103252308 · Cited by 53
Almholt, D. L. C., Loechel, F., Nielsen, S. J., Krog-Jensen, C., Terry, R., Bjørn, S. P., Pedersen, H. C., Præstegaard, M., Møller, S., Heide, M., et al. (2004) · Assay and Drug Development Technologies · doi:10.1089/154065804322966270 · Cited by 50
Development of a Binding Assay for p53/HDM2 by Using Homogeneous Time-Resolved Fluorescence
Kane, S. A., Fleener, C., Zhang, Y., Davis, L. J., Musselman, A., & Huang, P. S. (2000) · Analytical Biochemistry · doi:10.1006/abio.1999.4413 · Cited by 47
Wu, X. Y., Glickman, J. F., Bowen, B. R., & Sills, M. A. (2003) · SLAS DISCOVERY · doi:10.1177/1087057103256466 · Cited by 46
Measuring Drug Action in the Cellular Context Using Protein-Fragment Complementation Assays
Yu, H. W., West, M., Keon, B. H., Bilter, G. K., Owens, S., Lamerdin, J. E., & Westwick, J. K. (2003) · Assay and Drug Development Technologies · doi:10.1089/154065803772613444 · Cited by 45
β Galactosidase Enzyme Fragment Complementation as A Novel Technology for High Throughput Screening
Eglen, R. M., & Singh, R. K. (2003) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620703106298473 · Cited by 45
Transcreener™: screening enzymes involved in covalent regulation
Lowery, R. G., & Kleman-Leyer, K. M. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.1.179 · Cited by 44
Ferrer, M., Kolodin, G., Zuck, P. D., Peltier, R., Berry, K., MANDALA, S. M., Rosen, H., Ota, H., Ozaki, S., Inglese, J., et al. (2003) · Assay and Drug Development Technologies · doi:10.1089/15406580360545071 · Cited by 41
Self-citationZhou, G., Cummings, R. T., Hermes, J. D., & Moller, D. E. (2001) · Methods · doi:10.1006/meth.2001.1215 · Cited by 40
Hodder, P., Cassaday, J., Peltier, R., Berry, K., Inglese, J., Feuston, B. P., Culberson, C., Bleicher, L. S., Cosford, N. D. P., Bayly, C., et al. (2003) · Analytical Biochemistry · doi:10.1016/s0003-2697(02)00608-5 · Cited by 39
Self-citationβ Galactosidase Enzyme Fragment Complementation as a High-Throughput Screening Protease Technology
Naqvi, T., Lim, A., Rouhani, R., Singh, R. K., & Eglen, R. M. (2004) · SLAS DISCOVERY · doi:10.1177/1087057104264040 · Cited by 37
Inflammatory Pathway Analysis Using a High Content Screening Platform
Bertelsen, M., & Sanfridson, A. (2005) · Assay and Drug Development Technologies · doi:10.1089/adt.2005.3.261 · Cited by 36
Vázquez, J., Tautz, L., Ryan, J. J., Vuori, K., Mustelin, T., & Pellecchia, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061481l · Cited by 36
Oosterom, J., van Doornmalen, E. J. P., Lobregt, S., Blomenröhr, M., & Zaman, G. J. R. (2005) · Assay and Drug Development Technologies · doi:10.1089/adt.2005.3.143 · Cited by 36
Edwards, B. S., Young, S. M., Oprea, T. I., Bologa, C., Prossnitz, E. R., & Sklar, L. A. (2006) · Nature Protocols · doi:10.1038/nprot.2006.9 · Cited by 36
Johnston, P. A., Foster, C. A., Shun, T. Y., Skoko, J., Shinde, S. S., Wipf, P., & Lazo, J. S. (2007) · Assay and Drug Development Technologies · doi:10.1089/adt.2007.066 · Cited by 36
Knight, S. M. G., Umezawa, N., Lee, H., Gellman, S. H., & Kay, B. K. (2002) · Analytical Biochemistry · doi:10.1006/abio.2001.5468 · Cited by 35
Considerations for Using Fluorescence Polarization in the Screening of G Protein-Coupled Receptors
Banks, P., & Harvey, M. (2002) · SLAS DISCOVERY · doi:10.1177/108705710200700203 · Cited by 35
Wang, K., McIlvain, B., Tseng, E., Kowal, D. M., Jow, F., Shen, R., Zhang, H., Shan, Q. J., He, L., Chen, D. A., et al. (2004) · Assay and Drug Development Technologies · doi:10.1089/adt.2004.2.525 · Cited by 34
Bandyopadhyay, S., Ni, J., Ruggiero, A., Walshe, K., Rogers, M. S., Chattopadhyay, N., Glicksman, M. A., & Rogers, J. T. (2006) · SLAS DISCOVERY · doi:10.1177/1087057106287271 · Cited by 34
Adie, E. J., Francis, M. J., Davies, J., Smith, L., Marenghi, A., Hather, C., Hadingham, K. L., Michael, N. P., Milligan, G., & Game, S. M. (2003) · Assay and Drug Development Technologies · doi:10.1089/15406580360545062 · Cited by 33
Chin, J., Adams, A. D., Bouffard, A., Green, A., Lacson, R., Smith, T., Fischer, P. A., Menke, J. G., Sparrow, C. P., & Mitnaul, L. J. (2003) · Assay and Drug Development Technologies · doi:10.1089/154065803772613417 · Cited by 33
Auld, D. S., Johnson, R. L., Zhang, Y., Veith, H., Jadhav, A., Yasgar, A., Simeonov, A. M., Zheng, W., Martinez, E. D., Westwick, J. K., et al. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)14029-x · Cited by 29
Self-citationMackem, S., Baumann, C. T., & Hager, G. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100269200 · Cited by 29
Biosensing of opioids using frog melanophores
Karlsson, A. M. (2002) · Biosensors and Bioelectronics · doi:10.1016/s0956-5663(01)00284-6 · Cited by 29
Scheel, A. A., Funsch, B., Busch, M. P., Gradl, G., Pschorr, J., & Lohse, M. J. (2001) · SLAS DISCOVERY · doi:10.1177/108705710100600103 · Cited by 28
A Cell-Based Assay for I κ B α Stabilization Using A Two-Color Dual Luciferase-Based Sensor
Davis, R. E., Zhang, Y., Southall, N. T., Staudt, L. M., Austin, C. P., Inglese, J., & Auld, D. S. (2007) · Assay and Drug Development Technologies · doi:10.1089/adt.2006.048 · Cited by 28
Self-citationIssad, T., Blanquart, C., & González-Yanes, C. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.4.541 · Cited by 28
Wolff, M., Haasen, D., Merk, S., Kroner, M., Maier, U., Bordel, S., Wiedenmann, J., Nienhaus, G. U., Valler, M. J., & Heilker, R. (2006) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620706777452447 · Cited by 27
Whitney, M., Stack, J. H., Darke, P. L., Zheng, W., Terzo, J., Inglese, J., Strulovicil, B., Kuo, L. C., & Pollok, B. A. (2002) · Journal of biomolecular screening · doi:10.1089/10870570252906611 · Cited by 24
Self-citationWaddleton, D. M., Ramachandran, C., & Wang, Q. (2002) · Analytical Biochemistry · doi:10.1016/s0003-2697(02)00292-0 · Cited by 24
Confocal Fluorescence Microscopy for High-Throughput Screening of G-Protein Coupled Receptors
Heilker, R., Zemanová, L., Valler, M. J., & Nienhaus, G. U. (2005) · Current Medicinal Chemistry · doi:10.2174/092986705774370637 · Cited by 23
Zaman, G. J. R., van der Lee, M. M. C., Kok, J. J., et al. (2006) · Assay and Drug Development Technologies · doi:10.1089/adt.2006.4.411 · Cited by 22
John, S. P., Fletcher, T., & Jonsson, C. B. (2005) · SLAS DISCOVERY · doi:10.1177/1087057105276318 · Cited by 22
High Throughput Drug Screening for Human Immunodeficiency Virus Type 1 Reactivating Compounds
Jones, J., Rodgers, J. W., Heil, M. L., May, J. E., White, L., Maddry, J. A., Fletcher, T., Shaw, G. M., Hartman, J. L., & Kutsch, O. (2007) · Assay and Drug Development Technologies · doi:10.1089/adt.2006.040 · Cited by 20
Enomoto, K., Aono, Y., Mitsugi, T., Takahashi, K., Suzuki, R., Préaudat, M., Mathis, G., Kominami, G., & Takemoto, H. (2000) · SLAS DISCOVERY · doi:10.1177/108705710000500409 · Cited by 20
Turek-Etienne, T. C., Kober, T. P., Stafford, J. M., & Bryant, R. W. (2003) · Assay and Drug Development Technologies · doi:10.1089/154065803322302808 · Cited by 20
Newbatt, Y. M., Burns, S., Hayward, R., Whittaker, S. R., Kirk, R., Marshall, C. J., Springer, C. J., McDonald, E., Cancer Genome Project, Marais, R., et al. (2006) · SLAS DISCOVERY · doi:10.1177/1087057105283584 · Cited by 20
Assays for High‐Throughput Screening of E2 and E3 Ubiquitin Ligases
Kenten, J. H., Davydov, I. V., Safiran, Y. J., Stewart, D., Oberoi, P., & Biebuyck, H. A. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)99045-9 · Cited by 19
Gowda, K., Marks, B. D., Zielinski, T. K., & Ozers, M. S. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.06.029 · Cited by 19
Ross, S. L., Chen, T. C., Yu, V. L., Tudor, Y., Zhang, D., Liu, L., Tamayo, N. A., Dominguez, C., & Powers, D. A. (2006) · Assay and Drug Development Technologies · doi:10.1089/adt.2006.4.397 · Cited by 19
Labrecque, J., Anastassov, V., Lau, G., Darkes, M. C., Mosi, R., & Fricker, S. P. (2005) · Assay and Drug Development Technologies · doi:10.1089/adt.2005.3.637 · Cited by 17
Leblanc, V., Delaunay, V., Lelong, J., Gas, F., Mathis, G., Grassi, J., & May, E. (2002) · Analytical Biochemistry · doi:10.1016/s0003-2697(02)00229-4 · Cited by 17
Zhao, X., Vainshtein, I., Gellibolian, R., Shu, Y., Dotimas, H., Wang, X. M., Fung, P., Horecka, J., Bosano, B. L., & Eglen, R. M. (2003) · Assay and Drug Development Technologies · doi:10.1089/154065803772613453 · Cited by 17
A Nonadherent Cell-Based HTS Assay for N-Type Calcium Channel Using Calcium 3 Dye
Lubin, M. L., Reitz, T. L., Todd, M. J., et al. (2006) · Assay and Drug Development Technologies · doi:10.1089/adt.2006.4.689 · Cited by 15
Grånäs, C., Lundholt, B. K., Loechel, F., Pedersen, H.-C., Bjørn, S. P., Linde, V., Krog-Jensen, C., Nielsen, E.-M. D., Præstegaard, M., & Nielsen, S. J. (2006) · SLAS DISCOVERY · doi:10.1177/1087057106287136 · Cited by 14
Dynamic Green Fluorescent Protein Sensors for High‐Content Analysis of the Cell Cycle
Stubbs, S. L. J., & Thomas, N. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)14001-x · Cited by 13
Rodgers, G. H., Hubert, C., McKinzie, J. H., Suter, T. M., Statnick, M. A., Emmerson, P. J., & Stancato, L. F. (2003) · Assay and Drug Development Technologies · doi:10.1089/154065803770380986 · Cited by 13
Quantification of Small Molecule-Receptor Affinities and Kinetics by Acoustic Profiling
Li, X., Thompson, K. S. J., GODBER, B. L. J., & Cooper, M. A. (2006) · Assay and Drug Development Technologies · doi:10.1089/adt.2006.4.565 · Cited by 12
Su, J., Fornwald, J., Rivers, P., Goldsworthy, S. M., Looney, N. A., Hanvey, J. C., Plumpton, C., Parham, J. H., Romanos, M. A., Kost, T. A., et al. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.05.006 · Cited by 11
Novel Functional Assay for Proteases and Modulators: Application in β-Secretase Studies
Li, Y., Liu, Y.-W., & Cordell, B. (2001) · Molecular Biotechnology · doi:10.1385/mb:18:1:01 · Cited by 11
A fluorescence-based assay for the reductase activity of protein disulfide isomerase
Tomazzolli, R., Serra, M. D., Bellisola, G., Colombatti, M., & Guella, G. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.11.037 · Cited by 10
Atomic Absorption Spectroscopy in Ion Channel Screening
Stankovich, L., Wicks, D., Despotovski, S., & Dong, L. (2004) · Assay and Drug Development Technologies · doi:10.1089/1540658042584161 · Cited by 10
Zeh, K., Sanders, P., Londo, P., et al. (2003) · Assay and Drug Development Technologies · doi:10.1089/154065803772613390 · Cited by 6
Cited by
SwissTargetPrediction: a web server for target prediction of bioactive small molecules
Gfeller, D., Grosdidier, A., Wirth, M., Daina, A., Michielin, O., & Zoete, V. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku293 · Cited by 1,791
Bright Ideas for Chemical Biology
Lavis, L. D., & Raines, R. T. (2008) · ACS Chemical Biology · doi:10.1021/cb700248m · Cited by 1,290
Target identification and mechanism of action in chemical biology and drug discovery
Schenone, M., Dančík, V., Wagner, B. K., & Clemons, P. A. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1199 · Cited by 1,096
Target identification using drug affinity responsive target stability (DARTS)
Lomenick, B., Hao, R., Jonai, N., Chin, R. M., Aghajan, M., Warburton, S., Wang, J., Wu, R. P., Gomez, F., Loo, J. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910040106 · Cited by 1,095
Combinatorial Strategies in Fluorescent Probe Development
Vendrell, M., Zhai, D., Er, J. C., & Chang, Y.-T. (2012) · Chemical Reviews · doi:10.1021/cr200355j · Cited by 669
Metadata
- Authors
- Inglese, J., Johnson, R. L., Simeonov, A., Xia, M., Zheng, W., Austin, C. P., & Auld, D. S.
- Venue
- Nature Chemical Biology
- Published
- 2007-07-18
- Volume
- 3
- Issue
- 8
- Pages
- 466-479
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W2065915163
- Cited by
- 614
- References
- 175
- FWCI
- 46.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.